Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromatin proteins are a diverse set of proteins that associate with and regulate the structure and function of chromatin in eukaryotic cells. This group includes core histones (H2A, H2B, H3, H4), linker histones (H1), chromatin remodeling complex subunits (e.g., SWI/SNF, CHD, INO80 families), and chromatin-modifying enzymes (e.g., histone acetyltransferases, deacetylases, methyltransferases). Collectively, these proteins mediate chromatin packaging, regulation of gene expression, DNA replication, and repair. Specific members of this group (e.g., EZH2, HDACs, BRD4) have been identified as promising drug targets, especially in cancer, but the class as a whole is not a precise or actionable therapeutic entity.
As a general term, there is no single mechanism of action; mechanistic classes applicable to specific proteins within this class include inhibition of enzymatic modification (e.g., acetylation, methylation, phosphorylation) or disruption of chromatin binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromatin protein.